Boston Scientific Corp (BSX)
73.68
-0.42
(-0.57%)
USD |
NYSE |
May 10, 16:00
73.68
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific Cash from Financing (Quarterly): 1.569B for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.569B |
December 31, 2023 | 15.00M |
September 30, 2023 | 16.00M |
June 30, 2023 | 43.00M |
March 31, 2023 | -69.00M |
December 31, 2022 | 1.00M |
September 30, 2022 | -199.00M |
June 30, 2022 | -344.00M |
March 31, 2022 | -6.00M |
December 31, 2021 | -8.00M |
September 30, 2021 | 6.00M |
June 30, 2021 | 2.00M |
March 31, 2021 | -95.00M |
December 31, 2020 | -819.00M |
September 30, 2020 | -249.00M |
June 30, 2020 | 1.105B |
March 31, 2020 | 256.00M |
December 31, 2019 | -724.00M |
September 30, 2019 | 1.314B |
June 30, 2019 | 256.00M |
March 31, 2019 | 2.127B |
December 31, 2018 | 425.00M |
September 30, 2018 | 151.00M |
June 30, 2018 | 726.00M |
March 31, 2018 | 130.00M |
Date | Value |
---|---|
December 31, 2017 | -68.00M |
September 30, 2017 | -139.00M |
June 30, 2017 | 332.00M |
March 31, 2017 | -15.00M |
December 31, 2016 | 28.00M |
September 30, 2016 | 34.00M |
June 30, 2016 | -217.00M |
March 31, 2016 | -51.00M |
December 31, 2015 | -237.00M |
September 30, 2015 | 761.00M |
June 30, 2015 | 846.00M |
March 31, 2015 | -94.00M |
December 31, 2014 | -14.00M |
September 30, 2014 | 18.00M |
June 30, 2014 | 6.00M |
March 31, 2014 | -160.00M |
December 31, 2013 | -265.00M |
September 30, 2013 | -138.00M |
June 30, 2013 | -107.00M |
March 31, 2013 | -114.00M |
December 31, 2012 | -262.00M |
September 30, 2012 | -239.00M |
June 30, 2012 | -131.00M |
March 31, 2012 | -132.00M |
December 31, 2011 | -308.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-819.00M
Minimum
Dec 2020
1.569B
Maximum
Mar 2024
103.50M
Average
1.50M
Median
Cash from Financing (Quarterly) Benchmarks
ResMed Inc | -335.91M |
Stryker Corp | -418.00M |
Align Technology Inc | -11.72M |
Abbott Laboratories | -1.176B |
Axonics Inc | 0.248M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 164.00M |
Cash from Investing (Quarterly) | -285.00M |
Free Cash Flow | 1.553B |
Free Cash Flow Per Share (Quarterly) | -0.0547 |
Free Cash Flow to Equity (Quarterly) | -1.599B |
Free Cash Flow to Firm (Quarterly) | -25.05M |
Free Cash Flow Yield | 1.43% |